Acute and chronic effects of ketamine upon human memory: a review (Q36606041)

15 August 2017

1 reference

title

Acute and chronic effects of ketamine upon human memory: a review (English)

1 reference

15 August 2017

Celia J A Morgan

1

1 reference

PubMed ID

17006715

15 August 2017

H Valerie Curran

series ordinal

2

1 reference

15 August 2017

28 September 2006

1 reference

15 August 2017

1 reference

15 August 2017

188

1 reference

15 August 2017

4

1 reference

15 August 2017

408-424

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-006-0572-3

15 August 2017

0 references

cites work

Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0572-3

Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0572-3

Ketamine--can chronic use impair memory?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0572-3

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0572-3

Neuropsychological function in schizophrenia. Selective impairment in memory and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0572-3

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

21 January 2018

1 reference

12 December 2020

A role for NMDA-receptor channels in working memory.

1 reference

12 December 2020

Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits

1 reference

12 December 2020

Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment.

1 reference

12 December 2020

Reduction of Psychotomimetic Side Effects of Ketalar® (Ketamine) by Rohypnol®(Flunitrazepam) A Randomized, Double-Blind Trial

1 reference

12 December 2020

Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers.

1 reference

12 December 2020

Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response study

1 reference

12 December 2020

Long-term effects of ketamine: evidence for a persisting impairment of source memory in recreational users

1 reference

12 December 2020

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

1 reference

12 December 2020

Neural bases of learning and memory: functional neuroimaging evidence

1 reference

12 December 2020

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

1 reference

12 December 2020

Altered prefrontal dopaminergic function in chronic recreational ketamine users

1 reference

12 December 2020

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

12 December 2020

Triazolam and zolpidem: effects on human memory and attentional processes.

1 reference

12 December 2020

Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex.

1 reference

12 December 2020

Selective cognitive impairments associated with NMDA receptor blockade in humans

1 reference

12 December 2020

The effects of sub-anaesthetic doses of ketamine on memory, cognitive performance and subjective experience in healthy volunteers.

1 reference

12 December 2020

Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug

1 reference

12 December 2020

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

12 December 2020

A neurobiological basis for substance abuse comorbidity in schizophrenia

1 reference

12 December 2020

Neurotransmitter interactions in schizophrenia--therapeutic implications

1 reference

12 December 2020

Recovery of neuropsychological functions during reduction in use of phencyclidine

1 reference

12 December 2020

Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users.

1 reference

12 December 2020

Is Phencyclidine (PCP) Abuse Associated with Organic Mental Impairment?

1 reference

12 December 2020

Ketamine displaces the novel NMDA receptor SPET probe [(123)I]CNS-1261 in humans in vivo.

1 reference

12 December 2020

Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism

1 reference

12 December 2020

The effects of a subpsychotic dose of ketamine on recognition and source memory for agency: implications for pharmacological modelling of core symptoms of schizophrenia

1 reference

12 December 2020

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

1 reference

12 December 2020

NMDA receptor regulation of memory and behavior in humans

1 reference

12 December 2020

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

1 reference

12 December 2020

Ketamine-iorazepam. Attenuation of psychic sequelae of ketamine by lorazepam

1 reference

12 December 2020

Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects.

1 reference

12 December 2020

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

1 reference

12 December 2020

The episodic buffer: a new component of working memory?

1 reference

12 December 2020

Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study

1 reference

12 December 2020

Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an FMRI study.

1 reference

12 December 2020

Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation

1 reference

12 December 2020

Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.

1 reference

12 December 2020

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

1 reference

12 December 2020

A two-process theory of schizophrenia: evidence from studies in post-mortem brain

1 reference

12 December 2020

Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia.

1 reference

12 December 2020

Some normal and abnormal behavioral syndromes due to transmitter gating of opponent processes

1 reference

12 December 2020

Interactive effects of subanesthetic ketamine and haloperidol in healthy humans.

1 reference

12 December 2020

The functional neuroanatomy of episodic memory

1 reference

12 December 2020

A comparison of the effects of scopolamine and diazepam on working memory.

1 reference

12 December 2020

Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects

1 reference

12 December 2020

Brain region-specific changes in the expression of calcium sensor proteins after repeated applications of ketamine to rats

1 reference

12 December 2020

Triazolam-induced changes in alcoholic thought processes

1 reference

12 December 2020

The psychiatric aspects of chronic phencyclidine use: a study of chronic PCP users

1 reference

12 December 2020

A case of ketamine dependence.

1 reference

12 December 2020

Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later

1 reference

12 December 2020

NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans

1 reference

12 December 2020

Phencyclidine analogues inhibit NMDA-stimulated [3H]GABA release from cultured cortex neurons.

1 reference

12 December 2020

Greater vulnerability to the amnestic effects of ketamine in males.

1 reference

12 December 2020

Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers

1 reference

12 December 2020

Glutamate receptor expression in schizophrenic brain

1 reference

12 December 2020

Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of the subsequent retrieval task

1 reference

12 December 2020

Ketamine: behavioral effects of subanesthetic doses

1 reference

12 December 2020

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

1 reference

12 December 2020

Dissociation of human mid-dorsolateral from posterior dorsolateral frontal cortex in memory processing

1 reference

12 December 2020

Brain activation during automatic and controlled processing of semantic relations: a priming experiment using lexical-decision

1 reference

12 December 2020

Recent developments in working memory

1 reference

12 December 2020

Increased neurogenesis in a rat ketamine model of schizophrenia

1 reference

12 December 2020

Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

1 reference

12 December 2020

Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex

1 reference

12 December 2020

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

1 reference

12 December 2020

Intrahippocampal administration of a glycine site antagonist impairs working memory performance of rats.

1 reference

12 December 2020

Positron emission tomography study of phencyclidine users as a possible drug model of schizophrenia

1 reference

12 December 2020

Object retrieval/detour deficits in monkeys produced by prior subchronic phencyclidine administration: evidence for cognitive impulsivity.

1 reference

12 December 2020

The apolipoprotein E epsilon 4 allele is associated with blunting of ketamine-induced psychosis in schizophrenia. A preliminary report

1 reference

12 December 2020

Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers

1 reference

12 December 2020

Phencyclidine and ketamine intoxication: a study of four populations of recreational users

1 reference

12 December 2020

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Low dose ketamine increases prepulse inhibition in healthy men.

1 reference

12 December 2020

Study of a new schizophrenomimetic drug; sernyl.

1 reference

12 December 2020

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

1 reference

12 December 2020

Ketamine--its pharmacology and therapeutic uses.

1 reference

12 December 2020

The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat

1 reference

12 December 2020

Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function

1 reference

12 December 2020

Effect of ketamine on amino acid-evoked release of acetylcholine from rat cerebral cortex in vitro.

1 reference

12 December 2020

Attention, learning, and personality during ketamine emergence: a pilot study

1 reference

12 December 2020

Impaired recruitment of the hippocampus during conscious recollection in schizophrenia.

1 reference

12 December 2020

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.

1 reference

12 December 2020

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

1 reference

12 December 2020

The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers

1 reference

12 December 2020

Are semantic deficits in schizophrenia due to problems with access or storage?

1 reference

12 December 2020

Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study

1 reference

12 December 2020

Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats

1 reference

12 December 2020

In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users

1 reference

12 December 2020

Specific impairments of planning

1 reference

12 December 2020

The seven sins of memory. Insights from psychology and cognitive neuroscience

1 reference

12 December 2020

Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors

1 reference

12 December 2020

Total intravenous anaesthesia for military surgery. A technique using ketamine, midazolam and vecuronium

1 reference

12 December 2020

Episodic and declarative memory: role of the hippocampus

1 reference

12 December 2020

Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character

1 reference

12 December 2020

The effects of a sub-anaesthetic dose of ketamine on human selective attention.

1 reference

12 December 2020

Subanesthetic doses of ketamine, diazepam, and nitrous oxide for adult outpatient sedation.

1 reference

12 December 2020

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

1 reference

12 December 2020

Negative features, retrieval processes and verbal fluency in schizophrenia.

1 reference

12 December 2020

10.1007/S00213-006-0572-3

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17006715